Altai Protocol Library New Protocol: Venetoclax with Dexamethasone for Rel/Ref Myeloma with t(11;14) U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Protocol: Tucatinib with Trastuzumab and Pertuzumab for Maintenance in HER2-Positive Breast Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Protocol: Tiragolumab and Atezolizumab with Chemotherapy in 1st Line Advanced Esophageal SCC U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Protocol: Talquetamab + Teclistamab for Extramedullary Myeloma U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Tafasitamab with Rituximab/Lenalidomide for Rel/Ref Follicular Lymphoma U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Drug: Savolitinib with Osimertinib for EGFR-Mutated, MET-Amplified NSCLC U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Indication: Ribociclib + Letrozole for Low-Grade Serous Ovarian Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Pirtobrutinib vs. Ibrutinib in CLL U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Indication: Pirtobrutinib for Untreated CLL without del(17p) U. Darda Bayraktar, MD 2026-01-21
